Expression vector of long-chain non-coding RNALINC00472, tumor suppression reagent and application thereof
A technology of long-chain non-coding and expression vectors, applied in the field of expression vectors of long-chain non-coding RNA LINC00472, which can solve the problems of unknown function of lncRNA and achieve the effects of prolonging the action time, inhibiting growth, and high transfection efficiency
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0054] Example 1, the TP53 gene was introduced into nasopharyngeal carcinoma cells, and the expression of lncRNA LINC00472 was significantly upregulated
[0055] 1. Materials and methods:
[0056] 1.1 Reagents and kits
[0057] Common biochemical reagents such as agarose (agrose) and gel recovery kits were purchased from Shanghai Huashun Biological Engineering Co., Ltd. Mini Kit (Qiagen) extraction kit extracts RNA with improved quality, SuperScript TM The III (Invitrogen) kit reverse transcribed RNA into cDNA. The Luciferase Reporter Gene Detection Kit Dual-LuciferaseReporter Assay System was purchased from Promega. The nasopharyngeal carcinoma cells HNE2 used in the present invention are preserved by the Cancer Institute of Central South University. The RPMI1640 medium and fetal bovine serum used for cell culture, and the trypsin used for digesting cells are all products of Gibco, USA. The lncRNA chip is a product of Agilent, the chip size is 4*180K, and there are 4650...
Embodiment 2
[0087] Example 2, lncRNA LINC00472 inhibits nasopharyngeal carcinoma cell cycle arrest and induces apoptosis
[0088] 1. Materials and methods
[0089] 1.1 Reagents and kits
[0090] Restriction endonucleases Nhe I, EcoR V and T4 DNA ligase were purchased from TakaRa Company; TRIZOL TMReagent (Invitrogen); Plasmid Extraction Kit, Gel Recovery Kit (OMEGA); Reverse Transcription Kit (Promega); Proteinase K, DNase I, RNAsin, RNase A (GBICOL Company); Tetramethylazolazolium Blue ( MTT, Sigma); antibiotic G418 (Ameresc).
[0091] 1.2 Construction of pcDNA3.1-LINC00472 eukaryotic expression vector
[0092] We chose pcDNA3.1 blank vector (from Invitrogen Company) to construct the overexpression vector of LINC00472. We selected Nhe I and EcoR V restriction sites for restriction digestion of pcDNA3.1 vector and inserted LINC00472 sequence into this site.
[0093] The steps to construct the pcDNA3.1-LINC00472 eukaryotic vector are as follows:
[0094] 1) Using the cDNA of HNE2 cel...
Embodiment 3
[0143] Example 3, LINC00472 inhibits the growth of nasopharyngeal carcinoma cells in a nude mouse transplantation tumor model
[0144] 1. Materials and methods
[0145] Eight male BALB / C nude mice, 4 weeks old, weighing 19±2g, were purchased from Shanghai Slack Experimental Animal Co., Ltd. All nude mice passed the quality inspection and were bred under specific pathogen-free (SPF) conditions in the Experimental Animal Department of Central South University.
[0146] The construction of LINC00472 eukaryotic expression vector and the preparation, cell culture and transfection of polylysine-modified silicon nanoparticles are the same as in Example 2.
[0147] HNE2 cells transfected with LINC00472 or pcDNA3.1 blank vector, and HNE2 cells (Mock) without any treatment were taken 2×10 6 Inject into the subcutaneous of the armpits of nude mice respectively, observe and compare the growth of the tumors, measure the size of the transplanted tumors with a vernier caliper across the sk...
PUM
Property | Measurement | Unit |
---|---|---|
particle diameter | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com